Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A05 BILE AND LIVER THERAPY
A05A BILE THERAPY
A05AX Other drugs for bile therapy
A05AX06 Elafibranor
D11208 Elafibranor (USAN) <US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Gastrointestinal Agents, Other
Elafibranor
D11208 Elafibranor (USAN)
Drug groups [BR:br08330]
Metabolizing enzyme inducer
DG02853 CYP3A/CYP3A4 inducer
DG01635 CYP3A4 inducer
D11208 Elafibranor
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C1 (PPARA)
D11208 Elafibranor (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11208
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11208
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11208
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11208